AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 11 min read$JBLU

Sharma Vivek sold $27K of JBLU

Sharma Vivek sold 5,000 shares of JETBLUE AIRWAYS CORP (JBLU) at $5.40 on 2026-05-28.

Original reporting
SEC EDGAR · Sharma Vivek
Published Jun 1, 2026, 10:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 1, 2026, 10:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$JBLU
Neutral
low confidence
Mentioned
$JBLU
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JBLUNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider behavior but does not include any new company-specific fundamentals (earnings, guidance, deals, or legal/regulatory actions).

02

Market read

Traders may monitor for follow-on insider activity, but this single small sale is unlikely to reset valuation expectations.

03

What to watch

The filing does not disclose rationale; also, the dollar value is small, reducing signal-to-noise versus broader airline fundamentals.

Relevance 6/10Novelty 6/10Timing: Filed after-hours/late day (2026-06-01 18:51:32-04:00 filing time) following 2026-05-28 sale.

Background

The article is an SEC Form 4 insider transaction disclosure for JetBlue Airways Corp.

Company-level read

Ticker impact

$JBLUNeutralLow confidence
Context

JetBlue director Sharma Vivek filed an open-market sale of 5,000 shares at $5.40 on 2026-05-28 via SEC Form 4.

Expected impact

Likely limited near-term impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

Form 4 shows a director sale, but size ($27k) is modest versus typical market cap, and no 10b5-1 plan is cited; insider sales often have non-informational motives.

Market effects

Sector

Minimal; this is company-specific insider activity with no stated operational or regulatory catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

A director sale can be routine (taxes, diversification, liquidity) and the absence of a 10b5-1 plan does not automatically mean bearish information.

Key entities

  • issuer
    JBLU

    JetBlue Airways Corp; director Sharma Vivek sold 5,000 shares at $5.40.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

JBLU insider trading history →

Related articles

SEP 10
$JBLUMedAI 8/10

JetBlue raises third-quarter fuel price forecast

JetBlue Airways raised its third-quarter fuel price forecast to $3.96 per gallon, up from $3.49, due to elevated prices from the Iran war. The airline also reported higher operating costs from weather and air traffic disruptions. Despite these, it expects revenue per available seat mile to rise 17-20%, up from prior guidance of 12.5-16.5%. Shares were down 1% in premarket trading.

investing.com1 min
SEP 10
$JBLUHighAI 8/10

Why is JetBlue Airways stock climbing today?

JetBlue Airways (JBLU) stock rose 0.7% in pre-market trading after revising its Q3 2026 revenue guidance upwards to 17-20% YoY growth, up from 12.5-16.5%. The company also tightened its capacity outlook but increased its cost forecast due to weather disruptions. The move reflects company-specific optimism rather than broader market trends.

investing.com2 min
SEP 10
$JBLUHigh

JetBlue stock falls 3% despite raising revenue outlook

JetBlue (JBLU) shares fell 3% after raising its Q3 2026 revenue outlook to 17.0%-20.0% YoY growth, up from 12.5%-16.5%. Higher costs, including fuel and operational disruptions, offset the improved outlook, with CASM ex-Fuel expected to rise 6.0%-8.0% YoY. The airline also reduced its capacity growth outlook and lowered capital expenditures guidance to $275M.

investing.com2 min
AUG 17
$LUNRMed

Stocks making the biggest moves midday: EyePoint, Intuitive Machines, Workday, JetBlue & more

Midday movers included Intuitive Machines, up about 9% after saying it received an authorization to proceed for a $600 million multisatellite communications program. EyePoint Pharmaceuticals fell about 70% after its Phase 3 wet AMD treatment failed its primary goal. JetBlue dropped 6% after a Seaport Research downgrade. Onto Innovation rose on Goldman coverage. Workday fell after a Deutsche Bank downgrade. Memory chip stocks rose after comments on Apple buying Chinese chips.

cnbc.com7 min